Back to News
Market Impact: 0.25
Takeda Pharmaceutical Company Limited Reports Revenue of 2,406,997 Million JPY for the Six-month Period Ended September 30, 2026
Source: Nasdaq
Corporate EarningsCompany Fundamentals
Takeda reported revenue of ¥2,406,997 million and operating profit of ¥406,739 million for the six months ended September 30, 2026. Revenue increased 8.4% on an Actual Exchange Rate basis versus the prior-year six-month period; the provided article text does not include further results or outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
TAK0.35
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- Warren urges DOJ criminal probe of Bank of America over anti-money-laundering violations
- Taiwan Stocks Heads for Correction as Global AI Selloff Deepens